| 1 |
24858462 | Interferon alpha plus 13-cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501). | 2014 Jul |
2 |
| 2 |
25304678 | Phase 2 trial of paclitaxel, 13-cis retinoic acid, and interferon alfa-2b in the treatment of advanced stage or recurrent cervical cancer. | 2014 Nov |
1 |
| 3 |
20084480 | Antiproliferative effect of 13-cis-retinoic acid is associated with granulocyte differentiation and decrease in cyclin B1 and Bcl-2 protein levels in G0/G1 arrested HL-60 cells. | 2010 Sep |
1 |
| 4 |
20178647 | A randomized phase II trial of mitoxantrone, estramustine and vinorelbine or bcl-2 modulation with 13-cis retinoic acid, interferon and paclitaxel in patients with metastatic castrate-resistant prostate cancer: ECOG 3899. | 2010 Feb 24 |
2 |
| 5 |
21159604 | Antagonism of cytotoxic chemotherapy in neuroblastoma cell lines by 13-cis-retinoic acid is mediated by the antiapoptotic Bcl-2 family proteins. | 2010 Dec |
2 |
| 6 |
12768320 | A phase I trial of weekly paclitaxel, 13- cis-retinoic acid, and interferon alpha in patients with prostate cancer and other advanced malignancies. | 2003 Aug |
1 |
| 7 |
10604265 | Approaches to the treatment of patients with hormone-sensitive prostate cancer. | 1999 Oct |
3 |
| 8 |
10621853 | bcl-2 expression and apoptotic bodies in 13-cis-retinoic acid (isotretinoin)-topically treated oral leukoplakia: a pilot study. | 1999 May |
2 |
| 9 |
10638174 | The role of apoptosis and bcl-2 protein in topical treatment of oral leukoplakia with isotretinoin. | 1999 Sep |
2 |